The FDA Calls Kyowa Hakko Kirin's Lymphoma Drug a Breakthrough Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR… Source: BioSpace You Might Also Like Watch Out! Novartis AG Hungry for Small Takeover Targets With Early-Stage Drugs January 24, 2017 Capital Increase In Bavarian Nordic As A Result Of Employee Warrant Exercise May 17, 2017 Ex-Genentech Employees' Denali Breaks 2017 IPO Records, Raises $250M December 7, 2017
